External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

WCLC/IASLC 2021

-
Coming soon
09:04 AM
Duration 10mins Virtual
IMpower010: characterization of stage IB-IIIA NSCLC patients by type and extent of therapy prior to adjuvant atezolizumab▼
Felip E

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:50 PM
Duration 5mins Virtual
Evaluating circulating tumor DNA to predict overall survival risk in non-squamous non-small cell lung cancer in IMpower150
Zoe June Assaf, Alexander D. Fine, Wei Zou, Mark Socinski, Amanda Young, Jonathan F. Freidin, Mark Kennedy, Eliana Polisecki, Makoto Nishio, Geoff Oxnard, Craig Cummings, Anja Rhode, Martin Reck, Namrata S. Patil, David Shames, Katja Schulze

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:30 PM
Duration 5mins Virtual
LCMC3: immune cell subtypes predict pathologic response after neoadjuvant atezolizumab▼ in resectable NSCLC
Filiz Oezkan, Michal Seweryn, Maciej Pietrzak, Woo Yul Byun, Katja Schulze, Alan Nicholas, Ann Johnson, Jessica Grindheim, Dwight H. Owen, Bruce Johnson, Valerie Rusch, Mark Kris, Jay Lee, Ignacio Wistuba, David Kwiatkowski, Gerard Lozanski, David Carbone

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar